Summary.-When injected i.p. and in large numbers (107) into syngeneic mice, 125IUdR-labelled L1210 cells are rapidly destroyed in a small proportion of animals, while in the other animals the lysis is low. This bimodal distribution is clearly visible 24 h after cell injection. The intense lysis occurs in fewer animals when macrophagederived lysosomal enzymes are inhibited by trypan blue and if the complement is depleted by high doses of cobra venom factor (CVF). The intense destruction occurs in more animals after adjuvant treatment, if the mice are latently contaminated, after a moderate production of C3b by low doses of CVF, or after the injection of a tumourcell dialysate.
The destruction seems to be the result of positive feedback reaction which involves at least macrophages and complement activation.
In vivo tumour-cell destruction can be evaluated by a well established method based on the measurement of the radioactivity of mice injected i.p. with 125IUdR-labelled cells. The loss of 125J is a measure of the proportion of labelled cells that have been killed. In most animals of the control groups, the rate of elimination of the radioactivity is moderate, 15°/5 per day, well in accord with the published data (Hofer, Prensky and Hughes, 1969; Porteous and Munro, 1972) .
In a small number of animals, however, an intense immediate destruction can be observed, the frequency and the intensity of which we attempted to evaluate. The present paper reports some results which could suggest a mechanism.
MATERIAL AND METHODS
Animals. Specific-pathogen-free mice 6 weeks old were purchased from the Centre d'Elevage des Animaux du Laboratoire, Orleans la Source; DBA/2 and DBA/2 x C57BL/6 F1 (BDF1) hybrids were used. They were then kept in conventional conditions in our Institute and wvere used before they were 10 weeks old.
Tumour cells. Labelled tumour-cell injection was carried out following the method of Porteous and M1unro (1972) . BDF1 mice received i.p. 105 L1210 cells. Five days later, 4 injections of 1 juCi 125IUdR were given; on Day 7, the cells were harvested in Hanks' solution with added heparin, centrifuged, at 200 g in the cold, resuspended, counted and adjusted to the appropriate concentrations.
In order to minimize cell leakage at the injection site, (12 x 0 4 mm) hypodermic needles were used and inserted first s.c., then i.p. Uptake of the 1251 into the thyroid was prevented by including 0-1% of potassium iodide in the drinking water, starting from 2 days before the injection of labelled cells. The litter was changed every day to reduce the ingestion of radioactive sawdust.
Measuremnent of radioactivity.-Mice were introduced into a tube of appropriate size and counted in toto in a Packard y Counter, for 1 min.
Treatment of mice.-In some groups 1 mg live BCG was injected i.v. 2 weeks before the labelled cells. BCG was kindly provided by the Pasteur Institute under the form "Immuno BCG" which keeps 95% of its viability for 3 months at 4°C.
The cobra venom factor (CVF) was purchased from Cordis Laboratories, Miami, Florida, and given at high or low doses according to different protocols.
Trypan blue from Fluka was dialysed for 48 h against distilled water, lyophilized and resuspended at a concentration of 10 mg/ml in 0-15M NaCl. The mice received 4 mg i.p. 24 h and 1 mg i.p. 3 h before the injection of the cells.
Cell-free dialysates have been prepared as follows: L1210 cells or normal spleen and liver cells mixed in equal quantities were suspended in Hanks' solution at the concentration of 5 X 107 cells/ml. They were frozen and thawed twice and dialysed overnight at 4°C against twice their volume of RPMI 1640 medium pH 7 0.
Cytotoxic activity of the serum.-Blood of normal mice was taken by orbital puncture. The sera were individually tested for cytotoxicity against L1210 cells with complement according to Boyse, Old and Chouroulinkov (1964) .
Statistical analysis of the results.-The radioactivity of the mice was plotted in a histogram. It showed the existence of two generally well distinct groups. The x2 test (with Yates' correction for small numbers) was used to compare different protocols.
We also used Wilcoxon's test which does not require any hypothesis on the studied distributions: all the observations are ranked in increasing order, the comparisons being made between the ranks of the values of radioactivity counts after 2 different treatments.
RESULTS

Kinetics of cell destruction in normal mice
In our experiments 107, 5 x 106, 2 X 106 or 4 x 105 labelled cells were injected into mice which were counted in toto at different times after the cell injection.
It appears that 2 types of elimination may be observed: in some animals, the radioactivity stays at a high level, in others, the drop is visible by 3 h after cell injection.
A histogram was drawn, plotting the values of radioactivity of the mice immediately after the injection, and 3 and 24 h later (Fig. 1) . Progressivefy, 2 peaks are clearly visible. The separation remains 48 h after the cell injection. The rapid drop stops between 24 and 48 h. When the radioactivity is measured every day, the proportional decrease is then fairly similar in the 2 groups (Fig. 2 ).
In the following discussion, the group with a high rate of immediate cell destruction will be referred to as "high responder", the group with a low rate of cell destruction as "low responder".
The histogram of the survival time is approximately Gaussian but within it, the mice which were the last to die were usually those in which the labelling had diminished rapidly. (Hibbs, 1975) (Fig. 3) and significantly to shorten the survival of the mice (the x2 comparing the number of surviving animals in the control and untreated group on Day 12 is highly significant: X2 1175, P 0 O001).
We checked whether the trypan-blue treatment could modify the eliminatioin of the label of the lysed cells. A dose of adriamycin (10 mg/kg) which efficiently kills the L1210 cells, was injected into trypan-blue-treated mice. Most of the radioactive label was eliminated within a few hours, exactly as in non-trypanblue-treated mice.
Since macrophages from the labelled L1210-cell donor might play a role in the cytotoxicity observed in highresponder animals, we inhibited, in one experiment, these macrophages by treating the donors with trypan blue 24 h before harvesting tumour cells and injecting them into the recipients. Untreated donor animals were used as controls. The percentage of high responders was nearly the same in the 2 groups.
The amount of non-leukaemic cells in the inoculum was also evaluated; it has never been found to be more than 10% macrophages and 2% polynuclear cells.
Role of C3b component of complement
The injection of high doses of cobra venom factor (250 u/kg in 4 equal i.p. injections at 8h intervals within a 24h period) is known to reduce the serum C3 level by more than 9500 for more than 48h (Pepys, 1972 (Hofer, et al., 1969; Porteous and Munro, 1972; Sadler and Alexander, 1976) (Reif and Kim, 1971; Norbury and Fidler, 1975) . The rate of the loss of radioactivity is proportional to the rate of cell killing. The tumour line chosen is the chemically induced ascitic leukaemia L1210. When the cells are injected into DBA/2 (the original strain for the tumour) or Fl (DBA/2 x C57BL/6) mice they remain mostly in the peritoneal cavity.
When normal healthy mice are injected with labelled tumour cells, we observed, in a certain number of animals, an intense destructive capacity, while in the others the cell destruction is low. In the group with a high destruction rate the number of cells which are killed may be higher than 7500, even after injection of the 107 cells. This destruction is very rapid and already visible within 3 h. In spite of the high number of cells destroyed, death of the animals is only slightly delayed and no mouse survived: some form of regulation prevents the mechanism from being entirely efficient. It can be seen (Fig. 2) that the high cell-destruction rate has nearly finished within 24 h.
We are thus dealing with the existence of two groups of animals: one in which the tumour-cell destruction is low and one in which it is intense. These groups have been referred to as low and high responders. The different treatments given to the mice only displaced the animals from one group to the other; we rarely observed intermediate values.
If we consider a given group of animals we could explain the existence of high and low responders by a pre-existing heterogeneity or by one induced by the animal manipulation such as a cage effect or a leakage at the site of cell inoculation. To avoid this, we used mice of the same delivery, same age, randomized and very carefully injected. When we compare different groups of control or treated mice, if heterogeneity remains it is distributed at random between the groups and cannot by itself create a significant difference between them. If such a difference appears, and if it is reproducible, it should be attributed to the treatment.
There is much literature on the nonspecific cytotoxic effects against tumour cells. The transfer of the animals from an SPF environment to conventional conditions can induce the formation of heterophile and homophile antibodies, cross-reacting with various tumour cells. Natural and opsonic antibodies against a certain number of tumour lines have also been detected in the sera of all mouse strains. Some authors have also described a non-specific cell-mediated cytotoxicity by "natural killers" or by lymphocytes: "spontaneous lymphocytemediated cytotoxicity". Most of these studies are based on in vitro experiments. It is thus difficult to assert, without further exploration, that they could explain the intense in vivo cytotoxicity observed here, the more so as none of these authors has noticed a bimodal distribution of their observations in the cases where the individual cytotoxicity was measured.
We have measured the cytototoxicity of the serum of high-and low-responder mice and have not detected any correlation with the in vivo response. These results are in agreement with those of different authors. Pierotti and Colnaghi (1975) and Martin and Martin (1975) demonstrated that the level of natural antibodies against various syngeneic tumour lines in the serum of the DBA/2 and the C57BL/6 strains is low. Martin and Martin (1975) found that in the DBA/2 strain, the cytotoxicity of the serum against the L1210 ascitic cells was <2000. Menard, Colnaghi and Della Porta (1977) and Pierotti and Colnaghi (1976) showed that natural antibodies are not detectable before the age of 12 weeks (i.e. mice older than the animals we have used).
In the search for an effector cell, we treated mice with trypan blue, which specifically inhibits macrophage lysosomal-enzyme cytotoxic activity (Hibbs, tieatment, the high-responder group disappears almost entirely. This is not due to an alteration of the clearance of the label since, in try)an blute-adriamycintreated animals, the elimination of the radioactivity is very rapid after t,he cell destructioin by the drug.
We have already seen that the role of the few macr ophages present in the inoculum, which might have been held responsible for some of the cytotoxic activity, canI be ruled out. We can therefore conclude that the recipient's macrophages are inivolved in the ex)ression of the cytotoxicity described here.
The tumour-cell lysis observed has the characteristic of an "all or nothing" phenomenon, suggesting the existence of a self-perpetuating reactioin: this supposes that the trigger might be the same factor as the end product, which in its tuirn becomes the trigger: the reaction keeps oIn going until some factor stops it.
Among such positive feedback reactions, the amplification phase of complement activation can be considered as being possibly responsible for our observations, the trigger being the C3b component. This hypothesis is confirmed by the results of the CVF experiments. XVhen high doses of CVF are given, the C13 fraction is largely depleted at the time of the cell injection, and the formation of C3b by cleavage of C3 is very limited. The amplification loop of the complement activation cannot be triggered.
On the contrary, CVF given at low doses at the time of the cell injection is an activating factor which, through different stages, initiates the chain reaction without depleting the pool of C3 compoinen-it.
A positive feedback reaction within macrophages has been shown in vitro and in vivo (Bentley et al., 1976; BitterSuermain et al., 1976; Schorlemmer and Allison, 1976; Brade et al., 1974 The tumour-cell lysis could be explained by transfer of lysosomal enzymes of such stimulated macrophages (Hibbs, Lammert and Remington, 1972; Hibbs, 1975) .
The tumour-cell lysis could also be attributed to the C3a component produced with the C3b (Ferluga et al., 1976) . C3a also has a chemotactic role, attracting the macrophages to the tumour site.
In a recent paper, Pike and Snyderman (1976) Dialysate of normal cells can to a lesser extent also trigger the reaction; further studies are required to define the factors responsible for the enhanced activity. In conclusion, the early intense in vivo destruction of syngeneic tumour cells seems to imply the participation of the macrophages, of the cleavage products of C3, and of some tumour-cell components as trigger of the reaction.
It is not yet possible to extend our conclusions to the human situation, and to assume that the defence mechanisms described here play a role in cancer in man. It must, however, be noted that many products are known to enhance the alternate pathway of complement activation, among which some are used as adjuvants as, for instance, LPS. An activation of complement in patients submitted to immunotherapy by Corynebacterium parvum, leading to a fall in the C3 serum titre and in the appearance of C3 proactivator has been reported immediately after the C. parvum injection (Biran et al., 1976 
